On the basis of the high and consistent expression of prostate-specific membrane antigen (PSMA)
in metastatic prostate cancer (PC), the goal of this study was the development, …

Technical aspects and results of the dosimetric assessments of postoperative radioiodine
ablation in the framework of an international, prospective, controlled, randomized, comparative …

Prostate-specific membrane antigen (PSMA) is expressed in most prostate cancers and can
be identified by PSMA-ligand imaging, which has already become clinically accepted in …

Introduction In a recent publication, Jacobs et al. proposed the use of three tracer-dependent
dosage cards for paediatric nuclear medicine. Materials and methods Based upon this work…

Introduction The purpose of the EANM Dosimetry Committee Series on “Standard Operational
Procedures for Pre-therapeutic Dosimetry” (SOP) is to provide advice to scientists and …

The purpose of the present guidelines on the 131 I therapy of benign thyroid disorders
formulated by the European Association of Nuclear Medicine (EANM) Therapy Committee is to …

Chemokine receptor 4 (CXCR4) is a key factor for tumor growth and metastasis in several
types of human cancer. Based on promising experiences with a radiolabeled CXCR4 ligand ( …

Molecular radiotherapy (MRT) has demonstrated unique therapeutic advantages in the
treatment of an increasing number of cancers. As with other treatment modalities, there is related …

Meta-iodobenzylguanidine, or Iobenguane, is an aralkylguanidine resulting from the
combination of the benzyl group of bretylium and the guanidine group of guanethidine (an …

Purpose Investigating the value of 68 Ga-PSMA-PET/CT in biochemically recurring prostate
cancer patients with negative 18 F-choline-PET/CT. Patients and Methods One hundred thirty…